Investing Profile

Joseph Siletto

InvestorVC
Managing Director at VIVO Capital
Photo of Joseph Siletto, Managing Partner at Vivo Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
J.P. Morgan Network
318 CONNECTIONS
Bank of America Network
83 CONNECTIONS
cb
Vivo Capital Managing Partner
$10.0M - $50.0M
$25.0M
5
$1.4B
CompanyStageDateRound SizeTotal Raised
INBRACE
Series DSep 2021$100M
$150M
Co-investors: Peter Moldt (Novo Ventures), Aaron Royston (venBio)
Scientia Vascular
Private EquityMay 2021$50M
$50M
Co-investors: Nathan Dau (Vivo Capital)
Aerobiotix
Series UnknownMay 2021$25M
$25M
Co-investors: Nathan Dau (Vivo Capital)
Sera Prognostics
Series EApr 2021$100M
$140M
Co-investors: Tomer Berkovitz (aMoon Fund), Marc Singer (Osage University Partners), Kim P. Kamdar (Domain Associates), Doug Fisher (InterWest)
Preventice Solutions
Series BJul 2020$140M
$140M
Owner HotmailPresent
Manager HotmailPresent
Vice President Bank of AmericaPresent
Co-Head Life Sciences SVB AlliantPresent
Director Cowen Inc.Present
Managing Director VIVO CapitalPresent
Managing Director Vivo Capital Full-timePresent
Board Member Preventice SolutionsPresent
Board Member Serán BiosciencePresent
Board Observer Minerva Surgical, Inc.Present
Board Member INBRACEPresent
Board Observer NeocisPresent
Board Member Aerobiotix, Inc.Present
Board Member Sera PrognosticsPresent
Board Member HistoWizPresent
Board Member Scientia VascularPresent
Board Member AerobiotixPresent
Board Member Scientia Vascular, LLCPresent
Board Member Pathalys PharmaPresent
Co-Founder, CEO of North America and Europe Scion Medical TechnologiesPresent
Co-Founder/Angel Investor HotmailPresent
Chief Business Officer, Interim CEO, Board Observer Corza Wound ClosurePresent
Interim Chief Executive Officer HistoWizPresent
Interim Chief Executive Officer AerobiotixPresent
Managing Partner J.P. MorganPresent